Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
Saved in:
| Main Authors: | Lin Lu, Lei Xia, Xinhong Shi, Yingying Dai, Zipeng Wu, Yue Shi, Yingying Jiang, Yiling Liu, Yuxin Ma, Shuyi Hu, Ruofan Yu, Tianyi Liu, Caolu Liu, Jingwen Li, Guochun Cao, Delin Liu, Fei Yan, Jinghua Zhu, Xiaohua Wang, Lijun Zhao, Cheng Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01) -
Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study
by: Xiaoyou Li, et al.
Published: (2025-04-01) -
Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma
by: Xiaoyang Wang, et al.
Published: (2025-06-01) -
Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01) -
Pathologic complete response after neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Endoscopic characteristics and implications
by: Peng Yuan, et al.
Published: (2025-01-01)